Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 2

2632 - Ring-like uptake appearance on dedicated breast positron emission tomography before chemotherapy predicts outcome of neoadjuvant chemotherapy in breast cancer

Date

29 Sep 2019

Session

Poster Display session 2

Topics

Tumour Site

Breast Cancer

Presenters

Norio Masumoto

Citation

Annals of Oncology (2019) 30 (suppl_5): v55-v98. 10.1093/annonc/mdz240

Authors

N. Masumoto1, T. Kadoya2, M. Nishina3, Y. Kimura4, A. Amioka4, T. Itagaki4, S. Sasada4, A. Emi4, M. Okada4

Author affiliations

  • 1 Surgical Oncology, Hiroshima University, 734-0037 - Hiroshima/JP
  • 2 Surgical Oncology, Institute of Biomedical & Health Sciences, Hiroshima University, 734-8551 - Hiroshima/JP
  • 3 Surgical Oncology, Hiroshima University, 734-8551 - Hiroshima/JP
  • 4 Surgical Oncology, Hiroshima University, Hiroshima/JP

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2632

Background

Dedicated breast positron emission tomography (DbPET) with 18F-fluorodeoxyglucose (FDG) can detect intratumoral heterogeneity. In a previous study, we proved that intratumoral heterogeneous distribution of FDG on DbPET is significantly related to a high nuclear grade and high Ki-67 proliferation index; we also proved that DbPET is useful for predicting residual breast tumors after neoadjuvant chemotherapy (NAC). This study included patients with breast cancer who exhibited a ring-like uptake without central FDG accumulation on DbPET and aimed to evaluate whether the uptake can predict the effects of NAC in patients with breast cancer.

Methods

The study included 83 consecutive patients with breast cancer who subsequently underwent DbPET and NAC between August 2016 and March 2019 and evaluated the relationship between pathological response to NAC and clinicopathologic factors (clinical T1: n = 14; clinical N0: n = 33; nuclear grade 1 or 2: n = 22; Ki67 ≥ 20: n = 78; ER positive: n = 52; and HER-2 positive: n = 32), such as intratumoral heterogeneous distribution of FDG (positive: n = 54) and ring-like uptake without central FDG accumulation (positive: n = 11) on DbPET images.

Results

Surgical pathological findings obtained after the NAC indicated pathological complete response (pCR) and non-pCR in 32 (38.6%) and 51 (61.4%) patients, respectively. For all the patients, significant predictors for pCR were identified in univariate analyses (clinical T: odds ratio = 3.60, p = 0.03; clinical N: odds ratio = 2.48, p = 0.049; HER-2 overexpression: odds ratio = 2.72, p = 0.03; and ring-like uptake: odds ratio = 5.33, p = 0.01) and multivariate analyses (HER-2 overexpression: odds ratio = 3.29, p = 0.03; ring-like uptake: odds ratio = 17.6, p = 0.0006) (Table).Table:

279P Univariate and multivariate logistic analysis of significant predictive clinicopathological factors for pCR

CharacteristicUnivariate logistic analysisMultivariate logistic analysis
OR95%CIpOR95%CIp
Age, <50 v ≥ 501.380.57-3.380.481.970.65-5.980.23
Clinical T, T1 v T2- T43.601.11-12.90.033.860.97-15.40.06
Clinical N, Negative v Positive2.481.00-6.280.0492.860.97-8.420.06
Nuclear Grade, 3 v 1-21.490.54-4.380.451.650.41-6.700.48
Ki67, ≥20 v < 202.640.37-52.80.361.340.11-16.50.82
ER, Negative v Positive1.250.50-3.120.631.050.33-3.340.93
HER-2, Positive v Negative2.721.09-6.940.033.29 1.11-9.730.03
Intratumoral heterogenity, Positive v Negative1.500.59-3.780.391.690.43-6.570.45
Ring-like uptake, Positive v Negative5.331.40-26.10.0117.62.27-136.20.006

Conclusions

Ring-like uptake on DbPET provides predictive value for evaluating pCR to NAC in patients with breast cancer and might inform therapeutic decisions.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.